DIN 02539063 — ABSORICA LD 24 MG
ABSORICA LD is a capsule of Isotretinoin marketed by SUN PHARMACEUTICAL INDUSTRIES LIMITED. The full Isotretinoin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02539063
- Brand name
- ABSORICA LD
- Active ingredient
- Isotretinoin
- Strength
- 24 MG
- Dosage form
- CAPSULE
- Route
- ORAL
- Manufacturer
- SUN PHARMACEUTICAL INDUSTRIES LIMITED
- Health Canada status
- MARKETED
- Drug class
- Retinoid (systemic acne treatment)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Isotretinoin products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02539055 | ABSORICA LD | 16 MG | CAPSULE | SUN PHARMACEUTICAL INDUSTRIES LIMITED | MARKETED |
| 02539071 | ABSORICA LD | 32 MG | CAPSULE | SUN PHARMACEUTICAL INDUSTRIES LIMITED | MARKETED |
| 02539047 | ABSORICA LD | 8 MG | CAPSULE | SUN PHARMACEUTICAL INDUSTRIES LIMITED | MARKETED |
| 00582344 | ACCUTANE | 10 MG | CAPSULE | CHEPLAPHARM SCHWEIZ GMBH | MARKETED |
| 00582352 | ACCUTANE | 40 MG | CAPSULE | CHEPLAPHARM SCHWEIZ GMBH | MARKETED |
| 02257955 | CLARUS | 10 MG | CAPSULE | MYLAN PHARMACEUTICALS ULC | MARKETED |
| 02257963 | CLARUS | 40 MG | CAPSULE | MYLAN PHARMACEUTICALS ULC | MARKETED |
| 02396971 | EPURIS | 10 MG | CAPSULE | CIPHER PHARMACEUTICALS INC | MARKETED |
| 02396998 | EPURIS | 20 MG | CAPSULE | CIPHER PHARMACEUTICALS INC | MARKETED |
| 02397005 | EPURIS | 30 MG | CAPSULE | CIPHER PHARMACEUTICALS INC | MARKETED |
| 02397013 | EPURIS | 40 MG | CAPSULE | CIPHER PHARMACEUTICALS INC | MARKETED |